Angiogenesis and Fibrogenesis in Chronic Liver Diseases

Medina, 2004, Angiogenesis in chronic inflammatory liver disease, Hepatology, 39, 1185, 10.1002/hep.20193 Lee, 2007, Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?, Hepatology, 45, 817, 10.1002/hep.21564 Fernández, 2009, Angiogenesis in liver disease, J Hepatol, 50, 604, 10.1016/j.jhep.2008.12.011 Valfrè di Bonzo, 2009, Angiogenesis and liver fibrogenesis, Histol Histopathol, 23, 1324 Elpek, 2015, Angiogenesis and liver fibrosis, World J Hepatol, 7, 377, 10.4254/wjh.v7.i3.377 Bosch, 2010, Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension, J Hepatol, 53, 558, 10.1016/j.jhep.2010.03.021 Zhang, 2012, Fibrosis-dependent mechanisms of hepatocarcinogenesis, Hepatology, 56, 769, 10.1002/hep.25670 Kocabayoglu, 2013, Cellular basis of hepatic fibrosis and its role in inflammation and cancer, Front Biosci (Schol Ed), 5, 217, 10.2741/S368 Parola, 2008, Myofibroblast-like cells and liver fibrogenesis: emerging concepts in a rapidly moving scenario, Mol Asp Med, 29, 59, 10.1016/j.mam.2007.09.002 Rosmorduc, 2010, Hypoxia: a link between fibrogenesis, angiogenesis, and carcinogenesis in liver disease, Semin Liver Dis, 30, 258, 10.1055/s-0030-1255355 Novo, 2014, Cellular and molecular mechanisms in liver fibrogenesis, Arch Biochem Biophys, 548, 20, 10.1016/j.abb.2014.02.015 Cannito, 2014, Hypoxia, hypoxia-inducible factors and fibrogenesis in chronic liver diseases, Histol Histopathol, 29, 33 Fernandez, 2015, Molecular pathophysiology of portal hypertension, Hepatology, 61, 1406, 10.1002/hep.27343 Povero, 2013, Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require Vanin-1 for uptake by endothelial cells, Sci Signal, 6, ra88, 10.1126/scisignal.2004512 Lemoinne, 2015, Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles, Hepatology, 61, 1041, 10.1002/hep.27318 Nath, 2012, Hypoxia and hypoxia inducible factors: diverse roles in liver diseases, Hepatology, 55, 622, 10.1002/hep.25497 Friedman, 2008, Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver, Physiol Rev, 88, 125, 10.1152/physrev.00013.2007 Kisseleva, 2012, The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis, J Hepatol, 56, 965, 10.1016/j.jhep.2011.09.021 Lee, 2011, Mechanisms of hepatic fibrogenesis, Best Pract Res Clin Gastroenterol, 25, 195, 10.1016/j.bpg.2011.02.005 Forbes, 2011, Liver fibrogenic cells, Best Pract Res Clin Gastroenterol, 25, 207, 10.1016/j.bpg.2011.02.006 Mederacke, 2013, Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology, Nature Commun, 4, 2823, 10.1038/ncomms3823 Dranoff, 2010, Portal fibroblasts: Underappreciated mediators of biliary fibrosis, Hepatology, 51, 1438, 10.1002/hep.23405 Camenisch, 2002, ANGPTL3 stimulates endothelial cell adhesion and migration via integrin avβ3 and induces blood vessel formation in vivo, J Biol Chem, 277, 17281, 10.1074/jbc.M109768200 Coch, 2014, Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats, Hepatology, 60, 633, 10.1002/hep.26995 Semenza, 2011, Oxygen sensing, homeostasis and disease, N Engl J Med, 365, 537, 10.1056/NEJMra1011165 Semenza, 2012, Hypoxia inducible factors in physiology and medicine, Cell, 148, 399, 10.1016/j.cell.2012.01.021 Zhang, 2015, Update on implications and mechanisms of angiogenesis in liver fibrosis, Hepatol Res, 45, 162, 10.1111/hepr.12415 Corpechot, 2002, Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis, Hepatology, 35, 1010, 10.1053/jhep.2002.32524 Novo, 2007, Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells, Am J Pathol, 170, 1942, 10.2353/ajpath.2007.060887 Novo, 2012, The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells, J Pathol, 226, 588, 10.1002/path.3005 Moon, 2009, Reduced liver fibrosis in hypoxia-inducible factor-1 alpha-deficient mice, Am J Physiol Gastrointest Liver Physiol, 296, G582, 10.1152/ajpgi.90368.2008 Tugues, 2007, Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats, Hepatology, 46, 1919, 10.1002/hep.21921 Majumder, 2013, Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis, Eur J Pharmacol, 705, 86, 10.1016/j.ejphar.2013.02.026 Mejias, 2009, Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats, Hepatology, 49, 1245, 10.1002/hep.22758 Yoshiji, 2003, Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis, Gut, 52, 1347, 10.1136/gut.52.9.1347 Van Steenkiste, 2011, Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice, Hepatology, 53, 1629, 10.1002/hep.24238 Taura, 2008, Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis, Gastroenterology, 135, 1729, 10.1053/j.gastro.2008.07.065 Sahin, 2012, Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice, Hepatology, 55, 1610, 10.1002/hep.25545 Huang, 2012, Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats, Hepatology, 56, 248, 10.1002/hep.25625 Reichenbach, 2012, Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems, J Pharmacol Exp Ther, 340, 629, 10.1124/jpet.111.188078 Liu, 2013, A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling, Liver Int, 33, 504, 10.1111/liv.12034 Zhu, 2012, Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice, J Hepatol, 56, 893, 10.1016/j.jhep.2011.11.013 Thabut, 2011, Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis, Hepatology, 54, 573, 10.1002/hep.24427 Fernandez, 2004, Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice, Gastroenterology, 126, 886, 10.1053/j.gastro.2003.12.012 Fernandez, 2005, Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats, J Hepatol, 43, 98, 10.1016/j.jhep.2005.02.022 Fernandez, 2007, Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats, Hepatology, 46, 1208, 10.1002/hep.21785 Mejias, 2008, The somatostatin analogue octreotide inhibits angiogenesis in the earliest, but not in advanced, stages of portal hypertension in rats, J Cell Mol Med, 12, 1690, 10.1111/j.1582-4934.2008.00218.x Tiani, 2009, Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension, J Hepatol, 50, 296, 10.1016/j.jhep.2008.09.019 Mejias, 2015, Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats, Gut, 64, 657, 10.1136/gutjnl-2014-307138 Patsenker, 2009, Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis, Hepatology, 50, 1501, 10.1002/hep.23144 Kantari-Mimoun, 2015, Resolution of liver fibrosis requires myeloid cell-driven sinusoidal angiogenesis, Hepatology, 61, 2042, 10.1002/hep.27635 Coriat, 2011, Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib, PLoS One, 6, e16978, 10.1371/journal.pone.0016978 Shah, 2009, Antiangiogenic therapy: not just for cancer anymore?, Hepatology, 49, 1066, 10.1002/hep.22872 Duffy, 2013, Hemorrhagic events in hepatocellular carcinoma patients treated with antiangiogenic therapies, Hepatology, 57, 1068, 10.1002/hep.26120 Yang, 2014, Vascular endothelial growth factor promotes fibrosis resolution and repair in mice, Gastroenterology, 146, 1339, 10.1053/j.gastro.2014.01.061 Coulon, 2011, Angiogenesis in chronic liver disease and its complications, Liver Int, 31, 146, 10.1111/j.1478-3231.2010.02369.x Capece, 2013, The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages, Biomed Res Int, 2013, 187, 10.1155/2013/187204 Matsubara, 2013, TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis, Hepatology, 57, 1416, 10.1002/hep.25965 Solinas, 2009, Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation, J Leukoc Biol, 86, 1065, 10.1189/jlb.0609385 Tacke, 2012, Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo, Fibrogenesis Tissue Repair, 5, S27, 10.1186/1755-1536-5-S1-S27 Ehling, 2014, CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis, Gut, 63, 1960, 10.1136/gutjnl-2013-306294 Iwakiri, 2008, Vascular biology and pathobiology of the liver: report of a single-topic symposium, Hepatology, 47, 1754, 10.1002/hep.22203 Iwakiri, 2014, Vascular pathobiology in chronic liver disease and cirrhosis—current status and future directions, J Hepatol, 61, 912, 10.1016/j.jhep.2014.05.047 Geerts, 2001, History, heterogeneity, developmental biology and functions of quiescent hepatic stellate cells, Semin Liver Dis, 21, 311, 10.1055/s-2001-17550 Pinzani, 1992, Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients, J Clin Invest, 90, 642, 10.1172/JCI115905 Clemens, 1999, Regulation of sinusoidal perfusion: in vivo methodology and control by endothelins, Semin Liver Dis, 19, 383, 10.1055/s-2007-1007127 Kawada, 1995, Action of endothelins on hepatic stellate cells, J Gastroenterol, 30, 731, 10.1007/BF02349639 Pinzani, 1996, Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells, Gastroenterology, 110, 534, 10.1053/gast.1996.v110.pm8566602 Rockey, 1996, Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance, Hepatology, 24, 233, 10.1002/hep.510240137 Mallat, 1996, Growth inhibitory properties of endothelin-A in activated human stellate cells: a cyclic adenosine monophosphate-mediated pathway, J Clin Invest, 98, 2771, 10.1172/JCI119103 Shah, 1997, Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids, J Clin Invest, 100, 2923, 10.1172/JCI119842 Jarnagin, 1994, Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis, J Cell Biol, 127, 2037, 10.1083/jcb.127.6.2037 Rockey, 1998, Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells, Hepatology, 27, 472, 10.1002/hep.510270222 Michel, 1997, Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin, J Biol Chem, 272, 15583, 10.1074/jbc.272.25.15583 Fulton, 1999, Regulation of endothelium-derived nitric oxide production by the protein kinase Akt, Nature, 399, 597, 10.1038/21218 Langer, 2008, Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species, Hepatology, 47, 1983, 10.1002/hep.22285 Deleve, 2008, Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence, Hepatology, 48, 920, 10.1002/hep.22351 Rockey, 1995, Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility, J Clin Invest, 95, 1199, 10.1172/JCI117769 Ding, 2010, Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration, Nature, 468, 310, 10.1038/nature09493 Wang, 2012, Liver sinusoidal endothelial cell progenitor cells promote liver regeneration in rats, J Clin Invest, 122, 1567, 10.1172/JCI58789 Ding, 2014, Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis, Nature, 505, 97, 10.1038/nature12681 Ankoma-Sey, 2000, Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells, Hepatology, 31, 141, 10.1002/hep.510310122 Wang, 2004, Regulatory role of vHL/HIF-1α in hypoxia-induced VEGF production in hepatic stellate cells, Biochem Biophys Res Commun, 317, 358, 10.1016/j.bbrc.2004.03.050 Aleffi, 2005, Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells, Hepatology, 42, 1339, 10.1002/hep.20965 Copple, 2011, Hypoxia-inducible factor-1α regulates the expression of genes in hypoxic hepatic stellate cells important for collagen deposition and angiogenesis, Liver Int, 31, 230, 10.1111/j.1478-3231.2010.02347.x Novo, 2011, Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells, J Hepatol, 54, 964, 10.1016/j.jhep.2010.09.022 Busletta, 2011, Dissection of the biphasic nature of hypoxia-induced motogenic action in bone marrow-derived human mesenchymal stem cells, Stem Cells, 29, 952, 10.1002/stem.642 Ferrara, 2003, The biology of VEGF and its receptors, Nat Med, 9, 669, 10.1038/nm0603-669 Carmeliet, 2011, Molecular mechanisms and clinical applications of angiogenesis, Nature, 473, 298, 10.1038/nature10144 Nyberg, 2005, Endogenous inhibitors of angiogenesis, Cancer Res, 65, 3967, 10.1158/0008-5472.CAN-04-2427 Watanabe, 2004, Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis, J Clin Invest, 114, 898, 10.1172/JCI200421152 Chatterjee, 2014, Reversal of vasohibin-driven negative feedback loop of vascular endothelial growth factor/angiogenesis axis promises a novel antifibrotic therapeutic strategy for liver diseases, Hepatology, 60, 458, 10.1002/hep.27061 Principe, 2008, The hepatic apelin system: a new therapeutic target for liver disease, Hepatology, 48, 1193, 10.1002/hep.22467 Yokomori, 2011, Overexpression of apelin receptor (APJ/AGTRL1) on hepatic stellate cells and sinusoidal angiogenesis in human cirrhotic liver, J Gastroenterol, 46, 222, 10.1007/s00535-010-0296-3 Melgar-Lesmes, 2010, Apelin mediates the induction of profibrogenic genes in human hepatic stellate cells, Endocrinology, 151, 5306, 10.1210/en.2010-0754 Kitade, 2006, Leptin-mediated neovascularization is a prerequisite for progression of non-alcoholic steatohepatitis in rats, Hepatology, 44, 983, 10.1002/hep.21338 Semela, 2008, Platelet-derived growth factor signaling through ephrin-b2 regulates hepatic vascular structure and function, Gastroenterology, 135, 671, 10.1053/j.gastro.2008.04.010 Aleffi, 2011, Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells, Am J Physiol Gastrointest Liver Physiol, 301, G210, 10.1152/ajpgi.00047.2010 Copple, 2012, Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice, J Pharmacol Exp Ther, 341, 307, 10.1124/jpet.111.189340 Morel, 2011, Microparticles: A critical component in the nexus between inflammation, immunity, and thrombosis, Semin Immunopathol, 33, 469, 10.1007/s00281-010-0239-3 Rautou, 2011, Microparticles, vascular function, and atherothrombosis, Circ Res, 109, 593, 10.1161/CIRCRESAHA.110.233163 Rautou, 2012, Abnormal plasma microparticles impair vasoconstrictor responses in patients with cirrhosis, Gastroenterology, 143, 166, 10.1053/j.gastro.2012.03.040 Witek, 2009, Liver cell–derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells, Gastroenterology, 136, 320, 10.1053/j.gastro.2008.09.066 Kornek, 2012, Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis, Gastroenterology, 143, 448, 10.1053/j.gastro.2012.04.031 Lemoinne, 2014, The emerging roles of microvesicles in liver diseases, Nat Rev Gastroenterol Hepatol, 11, 350, 10.1038/nrgastro.2014.7